NATH BIOGENES (INDIA)
|
NATH BIOGENES (INDIA) Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹16 Cr |
Equity - Authorised | ₹21 Cr | ₹21 Cr | ₹21 Cr | ₹21 Cr | ₹17 Cr |
Equity - Issued | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹16 Cr |
Equity Paid Up | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹16 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹625 Cr | ₹591 Cr | ₹554 Cr | ₹523 Cr | ₹41 Cr |
Securities Premium | ₹134 Cr | ₹134 Cr | ₹134 Cr | ₹134 Cr | - |
Capital Reserves | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹13 Cr |
Profit & Loss Account Balance | ₹476 Cr | ₹441 Cr | ₹406 Cr | ₹374 Cr | ₹26 Cr |
General Reserves | ₹2.97 Cr | ₹2.97 Cr | ₹2.97 Cr | ₹2.97 Cr | ₹2.97 Cr |
Other Reserves | ₹0.92 Cr | ₹1.25 Cr | ₹0.33 Cr | ₹0.30 Cr | - |
Reserve excluding Revaluation Reserve | ₹625 Cr | ₹591 Cr | ₹554 Cr | ₹523 Cr | ₹41 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹644 Cr | ₹610 Cr | ₹573 Cr | ₹542 Cr | ₹57 Cr |
Minority Interest | - | - | - | ₹-0.01 Cr | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹1.61 Cr | ₹2.83 Cr | ₹0.40 Cr | ₹0.67 Cr | ₹1.05 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹1.61 Cr | ₹2.83 Cr | ₹0.40 Cr | ₹0.67 Cr | ₹1.05 Cr |
Unsecured Loans | ₹11 Cr | ₹2.04 Cr | - | - | ₹0.18 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | ₹11 Cr | ₹2.04 Cr | - | - | ₹0.18 Cr |
Deferred Tax Assets / Liabilities | - | - | - | - | ₹-0.90 Cr |
Deferred Tax Assets | - | - | - | - | ₹0.90 Cr |
Deferred Tax Liability | - | - | - | - | - |
Other Long Term Liabilities | - | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹3.54 Cr | ₹3.00 Cr | ₹2.79 Cr | ₹2.61 Cr | ₹1.47 Cr |
Total Non-Current Liabilities | ₹17 Cr | ₹7.87 Cr | ₹3.19 Cr | ₹3.28 Cr | ₹1.79 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹79 Cr | ₹43 Cr | ₹28 Cr | ₹43 Cr | ₹28 Cr |
Sundry Creditors | ₹79 Cr | ₹43 Cr | ₹28 Cr | ₹43 Cr | ₹28 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹176 Cr | ₹113 Cr | ₹84 Cr | ₹58 Cr | ₹53 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹37 Cr | ₹28 Cr | ₹15 Cr | ₹16 Cr | ₹5.18 Cr |
Interest Accrued But Not Due | ₹0.51 Cr | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹139 Cr | ₹85 Cr | ₹69 Cr | ₹42 Cr | ₹48 Cr |
Short Term Borrowings | ₹108 Cr | ₹104 Cr | ₹104 Cr | ₹92 Cr | ₹17 Cr |
Secured ST Loans repayable on Demands | ₹103 Cr | ₹99 Cr | ₹103 Cr | ₹90 Cr | ₹14 Cr |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹4.88 Cr | ₹4.91 Cr | ₹1.03 Cr | ₹1.88 Cr | ₹3.42 Cr |
Short Term Provisions | ₹1.24 Cr | ₹1.83 Cr | ₹0.87 Cr | ₹1.97 Cr | ₹0.29 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹0.39 Cr | ₹0.95 Cr | ₹0.28 Cr | ₹0.89 Cr | ₹0.10 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.85 Cr | ₹0.88 Cr | ₹0.59 Cr | ₹1.08 Cr | ₹0.19 Cr |
Total Current Liabilities | ₹365 Cr | ₹262 Cr | ₹216 Cr | ₹194 Cr | ₹98 Cr |
Total Liabilities | ₹1,026 Cr | ₹880 Cr | ₹793 Cr | ₹739 Cr | ₹157 Cr |
ASSETS | |||||
Gross Block | ₹279 Cr | ₹274 Cr | ₹270 Cr | ₹267 Cr | ₹77 Cr |
Less: Accumulated Depreciation | ₹29 Cr | ₹25 Cr | ₹25 Cr | ₹22 Cr | ₹39 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹250 Cr | ₹249 Cr | ₹244 Cr | ₹245 Cr | ₹38 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | - | - | - | - |
Non Current Investments | ₹5.78 Cr | ₹6.05 Cr | ₹5.05 Cr | ₹5.05 Cr | ₹0.00 Cr |
Long Term Investment | ₹5.78 Cr | ₹6.05 Cr | ₹5.05 Cr | ₹5.05 Cr | ₹0.00 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹5.78 Cr | ₹6.05 Cr | ₹5.05 Cr | ₹5.05 Cr | ₹0.00 Cr |
Long Term Loans & Advances | ₹80 Cr | ₹53 Cr | ₹24 Cr | ₹22 Cr | - |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹336 Cr | ₹309 Cr | ₹273 Cr | ₹272 Cr | ₹38 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹338 Cr | ₹230 Cr | ₹208 Cr | ₹220 Cr | ₹77 Cr |
Raw Materials | - | - | - | - | - |
Work-in Progress | ₹307 Cr | ₹211 Cr | ₹191 Cr | ₹190 Cr | ₹68 Cr |
Finished Goods | - | - | - | - | - |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹12 Cr | ₹6.91 Cr | ₹5.61 Cr | ₹6.12 Cr | ₹4.34 Cr |
Other Inventory | ₹19 Cr | ₹12 Cr | ₹11 Cr | ₹25 Cr | ₹5.12 Cr |
Sundry Debtors | ₹89 Cr | ₹94 Cr | ₹97 Cr | ₹86 Cr | ₹21 Cr |
Debtors more than Six months | ₹35 Cr | ₹55 Cr | ₹18 Cr | ₹62 Cr | ₹5.07 Cr |
Debtors Others | ₹68 Cr | ₹47 Cr | ₹87 Cr | ₹30 Cr | ₹17 Cr |
Cash and Bank | ₹89 Cr | ₹77 Cr | ₹38 Cr | ₹4.18 Cr | ₹2.48 Cr |
Cash in hand | ₹0.09 Cr | ₹0.03 Cr | ₹0.04 Cr | ₹0.05 Cr | ₹0.07 Cr |
Balances at Bank | ₹89 Cr | ₹77 Cr | ₹38 Cr | ₹4.13 Cr | ₹2.41 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹2.02 Cr | ₹0.47 Cr | ₹0.37 Cr | ₹0.40 Cr | ₹1.81 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹1.51 Cr | ₹0.08 Cr | ₹0.01 Cr | ₹0.05 Cr | - |
Prepaid Expenses | ₹0.43 Cr | ₹0.29 Cr | ₹0.36 Cr | ₹0.35 Cr | ₹0.15 Cr |
Other current_assets | ₹0.09 Cr | ₹0.10 Cr | - | - | ₹1.67 Cr |
Short Term Loans and Advances | ₹172 Cr | ₹169 Cr | ₹176 Cr | ₹157 Cr | ₹17 Cr |
Advances recoverable in cash or in kind | ₹251 Cr | ₹248 Cr | ₹259 Cr | ₹239 Cr | ₹13 Cr |
Advance income tax and TDS | ₹3.65 Cr | ₹5.11 Cr | ₹6.05 Cr | ₹6.89 Cr | ₹3.06 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹-83 Cr | ₹-84 Cr | ₹-88 Cr | ₹-89 Cr | ₹0.78 Cr |
Total Current Assets | ₹690 Cr | ₹572 Cr | ₹520 Cr | ₹468 Cr | ₹120 Cr |
Net Current Assets (Including Current Investments) | ₹325 Cr | ₹309 Cr | ₹303 Cr | ₹273 Cr | ₹22 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,026 Cr | ₹880 Cr | ₹793 Cr | ₹739 Cr | ₹157 Cr |
Contingent Liabilities | ₹89 Cr | ₹92 Cr | ₹72 Cr | ₹61 Cr | ₹0.34 Cr |
Total Debt | ₹123 Cr | ₹110 Cr | ₹105 Cr | ₹93 Cr | ₹19 Cr |
Book Value | 339.08 | 320.94 | 301.61 | 285.16 | 35.91 |
Adjusted Book Value | 339.08 | 320.94 | 301.61 | 285.16 | 35.91 |
Compare Balance Sheet of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹335.8 Cr | 1% | -7% | -22.6% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,567.3 Cr | -3.4% | -8.6% | -28.9% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,934.0 Cr | 7.9% | 2.8% | 3.6% | Stock Analytics | |
VENKYS (INDIA) | ₹2,104.2 Cr | 5.8% | -3.8% | -33.7% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,494.6 Cr | 7.5% | 2.3% | -30.7% | Stock Analytics | |
INDO US BIOTECH | ₹300.0 Cr | -3.5% | -11.9% | -41.7% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | 1% |
-7% |
-22.6% |
SENSEX | 0.5% |
-1.3% |
0.9% |
You may also like the below Video Courses